Clinical Trials Sponsored by Ipsen Biopharmaceuticals

Total 1117 results

Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Not yet recruiting

The Study of Long-term Outcomes of GR1802 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Recruiting

Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE

Lupus Erythematosus, Systemic

China
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Recruiting

The Study of Single Dose Administration of GR2002 Injection in Chinese Health Volunteers

Asthma

China
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Recruiting

The Study of GR1802 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps

China
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Recruiting

Study to Evaluate GR1801's Efficacy and Safety

Rabies Post-exposure Prophylaxis

China
SUNHO（China）BioPharmaceutical CO., Ltd.

Recruiting

To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Metastatic Colorectal Cancer

HER2 Gene Mutation

China
Curon Biopharmaceutical (Shanghai) Co.,Ltd

Recruiting

A Phase Ib/II Study of CN201 in Precursor B-cell Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

China
SUNHO（China）BioPharmaceutical CO., Ltd.

Recruiting

A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors

Advanced Malignant Tumors

China
Bliss Biopharmaceutical (Hangzhou) Co., Ltd

Recruiting

A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors

Solid Tumor

China
SUNHO（China）BioPharmaceutical CO., Ltd.

Recruiting

Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors

Advanced Solid Tumor

China
FutureGen Biopharmaceutical (Beijing) Co., Ltd

Recruiting

Safety, Tolerability and Pharmacokinetic Profile of M108 Monoclonal Antibody in Patients With Advanced Unresectable Solid Tumors in China

Advanced Unresectable Solid Tumors

China
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 in Chinese Healthy Adults

Tetanus

China
Shanghai Huaota Biopharmaceutical Co., Ltd.

Completed

A Study to Evaluate Multi-dose of HB0034 in Healthy Adult Participants

Healthy

New Zealand
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Completed

to Evaluate the Preliminary Efficacy and Safety of GR1501 Injection in Patients With Active Axial Spondyloarthritis

Axial Spondyloarthritis

China
Shanghai Huaota Biopharmaceutical Co., Ltd.

Completed

A Study to Evaluate HB0034 in Healthy Adult Participants

Healthy

New Zealand
Tasly Tianjin Biopharmaceutical Co., Ltd.

Unknown

Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients

Hepatitis B Virus (HBV)

China
Biocity Biopharmaceutics Co., Ltd.

Recruiting

A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease

Diabetic Kidney Disease | IgA Nephropathy

China
Apsen Farmaceutica S.A.

Completed

Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain (APS003/2020)

Osteoarthritis

Brazil
Apsen Farmaceutica S.A.

Completed

Phase I Study to Evaluate the Safety of Dexibuprofen 200mg Under Fasting and Fed Conditions

Healthy Volunteers

Brazil
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

A First-in-Human Study of QY211 Gel in Adult Subjects

Atopic Dermatitis

China
Angitia Biopharmaceuticals
Angitia Australia Pty Ltd

Completed

A First-in-Human Study Evaluating AGA2118 in Men and Postmenopausal Women

Osteoporosis

Australia
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Completed

A First-in-Human Study of QY101 Ointment in Adult Subjects

Healthy Volunteer

China
Soroka University Medical Center
Eiger BioPharmaceuticals

Active, not recruiting

Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus Infection (LOWR6)

Hepatitis D, Chronic

Israel, New Zealand, Turkey
Keryx Biopharmaceuticals
Collaborative Study Group (CSG)

Terminated

Effect of Sulodexide in Overt Diabetic Nephropathy

Diabetic Nephropathy

United States, Australia, Netherlands
Keryx Biopharmaceuticals
Collaborative Study Group (CSG)

Completed

Effect of Sulodexide in Early Diabetic Nephropathy

Diabetic Nephropathy

United States, Australia, Netherlands
Latin American Cooperative Oncology Group
Ipsen

Recruiting

Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American

Kidney Neoplasms

Brazil
Emory University
Ipsen; Taiho Oncology, Inc.

Recruiting

TAS102 in Combination With NAL-IRI in Advanced GI Cancers

Gastric Adenocarcinoma | Unresectable Pancreatic Carcinoma | Metastatic Pancreatic Adenocarcinoma | Stage III Pancreatic Cancer | Stage IV Pancreatic Cancer | Colorectal Adenocarcinoma | Stage IV Gastric Cancer | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Stage... and other conditions

United States
Epizyme, Inc.
Swedish Cancer Institute

Terminated

SYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma

Follicular Lymphoma

United States
Assistance Publique - Hôpitaux de Paris
Ipsen

Completed

Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors (TNE-bien-DIF)

Neuroendocrine Tumors

France
Rajavithi Hospital
Ipsen; Chiang Mai University

Completed

Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study

Migraine Without Aura Prophylaxis

Thailand
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR).

Allergic Rhinitis
SUNHO（China）BioPharmaceutical CO., Ltd.

Not yet recruiting

A Study of IAP0971 in Combination With Bacillus Calmette Guerin in High Risk Non-muscular Invasive Bladder Cancer

Bladder Cancer
Suzhou Kanova Biopharmaceutical Co., LTD

Not yet recruiting

Phase I of XKH002 Injection in Patients

Advanced or Metastatic Solid Tumors
SUNHO（China）BioPharmaceutical CO., Ltd.

Recruiting

A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors

Advanced Malignant Tumors

China
Beijing QL Biopharmaceutical Co.,Ltd

Enrolling by invitation

A Study of ZT002 Injection in Participants With Overweight or Obesity

Overweight or Obesity

China
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd.

Completed

A Study of AK0529 in Chinese Infants Hospitalized With RSV (AIRFLO)

Respiratory Syncytial Virus Infections

China
Tasly Tianjin Biopharmaceutical Co., Ltd.

Unknown

Safety, Tolerability and Pharmacokinetics Characteristics of Recombinant Oncolytic Vaccinia Virus Injection T601 as a Single Drug or in Combination With Oral Flucytosine (5-FC), in Patients With Advanced Malignant Solid Tumors

Advanced Malignant Solid Tumors

China
Biocity Biopharmaceutics Co., Ltd.

Not yet recruiting

SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer

Advanced Ovarian Cancer | Serous Ovarian Cancer
Biocity Biopharmaceutics Co., Ltd.

Recruiting

A Phase I Study of BC3402 as a Single Agent in Patients With MDS and CMML

Hematologic Malignancy

China
Apsen Farmaceutica S.A.

Completed

Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain (APS002/2020)

Low Back Pain | Low Back Pain, Mechanical | Acute Low Back Pain

Brazil
Apsen Farmaceutica S.A.

Terminated

Phase III Efficacy and Tolerability Trial of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus Isolated Active Substances in Pain Control After Impacted Third Molar Extraction (FDCETCB-III)

Pain, Acute

Brazil
Apsen Farmaceutica S.A.

Withdrawn

Efficacy And Safety Study Of Naftopidil to Patients Treatment With LUTS

Hyperplasia

Brazil
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Recruiting

A Study of QY101 Ointment in Subjects With Plaque Psoriasis

Psoriasis

China
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
IQVIA RDS

Recruiting

A Study Of IMM47 In Subjects With Advanced Solid Tumors

Oncology

Australia
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd.

Completed

A Phase III Study to Evaluate Efficacy and Safety of TG-2349 in Combination With DAG181 and RBV for HCV Type I Patients

Cirrhosis | Chronic Hepatics C Virus (HCV) Genotype 1 | Non-Cirrhotic | Treatment naïve

China
Tracey McLaughlin
Eiger BioPharmaceuticals

Completed

Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia

Post Bariatric Hypoglycemia

United States
Keryx Biopharmaceuticals
Collaborative Study Group (CSG)

Terminated

Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

Diabetic Nephropathy

Australia
M.D. Anderson Cancer Center
Keryx Biopharmaceuticals

Completed

Perifosine and Docetaxel in Patients With Relapsed Epithelial Ovarian Cancer

Ovarian Cancer

United States
Hadassah Medical Organization
Morria Biopharmaceuticals PLC

Completed

Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis

Allergic Contact Dermatitis

Israel
Keryx Biopharmaceuticals
Collaborative Study Group (CSG)

Completed

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

End-Stage Renal Disease | Hyperphosphatemia

United States, Puerto Rico

Clinical Trials Sponsored by Ipsen Biopharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations